Replay available

Glaukos Corporation (GKOS) Q2 2026 Earnings Call

Glaukos Corporation (NYSE: GKOS) Q2 2026 earnings conference call, held 2026-07-29. Replay captured from the company's public earnings webcast.

Wed, July 29, 2026 at 4:30 PMendedReplay
Glaukos Corporation (GKOS) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Chris Lewis

Vice President of Investor Relations and Corporate Affairs

Tom Burns

Chairman and CEO

Joe Gilliam

President and COO

Alex Thurman

Chief Financial Officer

Replay transcript excerpt

Hello and welcome to Glaucus Corporation's second quarter 2026 financial results conference call. Copies of the company's press release and quarterly summary document, both issued after the market closed today, are available at www.glaucus.com. After today's prepared remarks, we will host a question and answer session. If you would like to ask a question, please press star 1 to raise your hand. To withdraw your question, press star 1 again. This call is being recorded and an archived replay will be available online in the investor relations section at www.glaucus.com. I will now turn the call over to Chris Lewis, Vice President of Investor Relations and Corporate Affairs. Thank you and good afternoon. Joining me today are Glaucus Chairman and CEO Tom Burns, President and COO Joe Gilliam, and CFO Alex Thurman. Similar to prior quarters, the company has posted a document on its investor relations website under the financials and filings quarterly results section, title quarterly summary. This document is designed to be read by investors before the regularly scheduled quarterly conference call. To ensure ample time and opportunity to address everyone's questions, We request that you limit yourself to only one question. Please note this is a change versus our previous calls. If you still have additional questions, you may get back into the queue. Please note that all statements other than statements of historical facts made on this call that address activities, events, or developments we expect, believe, or anticipate will or may occur in the future forward-looking statements. These include statements about our plans, objectives, strategies, and prospects regarding, among other things, our sales, products, pipeline technologies and clinical trials, U.S. and international...

More from Glaukos Corporation